Vistagen Therapeutics Inc (VTGN)
4.50
+0.09
(+2.04%)
USD |
NASDAQ |
May 03, 16:00
4.49
-0.01
(-0.22%)
Pre-Market: 20:00
Vistagen Therapeutics Price: 4.50 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 4.47 | 4.55 | 4.31 | 4.50 | 189633.0 |
May 02, 2024 | 4.82 | 4.82 | 4.37 | 4.41 | 319470.0 |
May 01, 2024 | 4.85 | 4.93 | 4.72 | 4.74 | 132036.0 |
Apr 30, 2024 | 4.77 | 4.96 | 4.65 | 4.83 | 474528.0 |
Apr 29, 2024 | 4.76 | 4.95 | 4.755 | 4.77 | 178261.0 |
Apr 26, 2024 | 4.71 | 4.85 | 4.65 | 4.75 | 194533.0 |
Apr 25, 2024 | 4.81 | 4.81 | 4.55 | 4.70 | 194805.0 |
Apr 24, 2024 | 4.85 | 4.86 | 4.65 | 4.72 | 147555.0 |
Apr 23, 2024 | 4.85 | 5.00 | 4.78 | 4.83 | 189955.0 |
Apr 22, 2024 | 4.83 | 4.87 | 4.735 | 4.78 | 138367.0 |
Apr 19, 2024 | 4.68 | 4.78 | 4.655 | 4.76 | 152293.0 |
Apr 18, 2024 | 4.72 | 4.82 | 4.60 | 4.70 | 197530.0 |
Apr 17, 2024 | 4.71 | 4.80 | 4.66 | 4.67 | 116230.0 |
Apr 16, 2024 | 4.64 | 4.81 | 4.40 | 4.65 | 180739.0 |
Apr 15, 2024 | 4.95 | 4.969 | 4.62 | 4.75 | 274505.0 |
Apr 12, 2024 | 5.24 | 5.36 | 4.84 | 4.89 | 321995.0 |
Apr 11, 2024 | 5.12 | 5.41 | 5.07 | 5.305 | 227380.0 |
Apr 10, 2024 | 5.11 | 5.23 | 5.05 | 5.10 | 168474.0 |
Apr 09, 2024 | 5.20 | 5.39 | 5.18 | 5.37 | 173328.0 |
Apr 08, 2024 | 5.08 | 5.24 | 5.00 | 5.17 | 115708.0 |
Apr 05, 2024 | 5.25 | 5.25 | 4.97 | 5.04 | 260388.0 |
Apr 04, 2024 | 5.40 | 5.74 | 5.26 | 5.29 | 448420.0 |
Apr 03, 2024 | 5.30 | 5.540 | 5.27 | 5.38 | 187252.0 |
Apr 02, 2024 | 5.22 | 5.49 | 5.06 | 5.40 | 304588.0 |
Apr 01, 2024 | 5.40 | 5.74 | 5.08 | 5.40 | 941526.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.68
Minimum
Jul 27 2023
103.50
Maximum
Jul 01 2021
27.46
Average
19.86
Median
Jul 16 2019
Price Benchmarks
Ardelyx Inc | 8.72 |
Axsome Therapeutics Inc | 74.80 |
Vir Biotechnology Inc | 10.39 |
Immuneering Corp | 1.64 |
NovaBay Pharmaceuticals Inc | 0.0949 |
Price Related Metrics
PS Ratio | 58.25 |
Price to Book Value | 0.9864 |
Earnings Yield | -77.98% |
Market Cap | 121.61M |